Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
- Status
- AVAILABLE
- Phase
- N/A
Urine DNA Methylation Detection for Hematuria Evaluation
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)
- Status
- WITHDRAWN
- Phase
- PHASE2
Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France
- Status
- TERMINATED
- Phase
- N/A
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
- Status
- RECRUITING
- Phase
- N/A
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 3 Study of UGN-103 for Treatment of Patients With Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
- Status
- RECRUITING
- Phase
- N/A
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
- Status
- RECRUITING
- Phase
- N/A